Bad Drugs, Fatal Kidney Injury
BPOM is criticized for its slow investigation into the ingredients of syrup medicines responsible for acute kidney injury. Some see the agency as protecting the pharmaceutical industry.
Hussein Abri Dongoran
October 31, 2022
WHEN leaders of the Indonesian Pharmaceutical Companies Association (GP Farmasi) met with Chair of the Food and Drug Monitoring Agency (BPOM), Penny Kusumastuti Lukito, at her office on Sunday afternoon, October 23, they discussed five syrup medicine brands that had been tied to acute kidney injury cases. During the meeting at the BPOM office, GP Farmasi asked the agency to refrain from announcing said drugs.
“We asked that, before they&rs
...